The first stop for professional medicines advice

Abatacept

Published
Topics: AbataceptAllergy and immunologyMusculo-skeletal disorders · New MedicinesNHS England commissioned new medicinesPatent expiriesSafety in BreastfeedingStability outside the fridge ·
Contents
  1. dm+d
  2. Refrigerated Storage
    1. Orencia · Bristol-Myers Squibb Pharmaceuticals Ltd
    2. Orencia · Bristol-Myers Squibb Pharmaceuticals Ltd
  3. Lactation Safety Information

dm+d

421412005

Refrigerated Storage

OrenciaBristol-Myers Squibb Pharmaceuticals Ltd

Bristol-Myers Squibb Pharmaceuticals Ltd
Orencia
Pre-filled syringe and pen

Contact Bristol-Myers Squibb Pharmaceuticals Ltd in all cases where deviation from the recommended storage conditions has occurred. Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

24 September 2021
London MI Service

OrenciaBristol-Myers Squibb Pharmaceuticals Ltd

Bristol-Myers Squibb Pharmaceuticals Ltd
Orencia
250mg powder for concentrate for solution for infusion

Contact Bristol-Myers Squibb Pharmaceuticals Ltd in all cases where deviation from the recommended storage conditions has occurred.Refer to the current BNF for company contact details.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

24 September 2021
London MI Service

Lactation Safety Information

Caution
See summary
Long half-life increases risk of accumulation in breastfed infants
Low levels anticipated in milk due to the drug's properties
No published evidence of safety
Avoid in preterm infants and neonates as large protein molecules may appear in colostrum
16 September 2020
LactMed